RXO, Inc.RXONYSE
Loading
EBITDA Over TimeContracting
Percentile Rank0
3Y CAGR-51.4%
5Y CAGR-29.0%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-51.4%/yr
Annual compound
5Y CAGR
-29.0%/yr
Recent deceleration
Percentile
P0
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$24.00M-79.5%
2024$117.00M-12.7%
2023$134.00M-35.9%
2022$209.00M-23.2%
2021$272.00M+104.5%
2020$133.00M-19.9%
2019$166.00M-